Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female Subjects

This study has been completed.
Genentech, Inc.
Information provided by:
Abbott Identifier:
First received: November 23, 2009
Last updated: November 8, 2010
Last verified: September 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)